» Articles » PMID: 31145782

Prevalence of Infective Endocarditis in Patients with Positive Blood Cultures: a Danish Nationwide Study

Abstract

Aims: Increasing attention has been given to the risk of infective endocarditis (IE) in patients with certain blood stream infections (BSIs). Previous studies have been conducted on selected patient cohorts, yet unselected data are sparse. We aimed to investigate the prevalence of IE in BSIs with bacteria typically associated with IE.

Methods And Results: By crosslinking nationwide registries from 2010 to 2017, we identified patients with BSIs typically associated with IE: Enterococcus faecalis (E. faecalis), Staphylococcus aureus (S. aureus), Streptococcus spp., and coagulase negative staphylococci (CoNS) and examined the concurrent IE prevalence. A trend test was used to examine temporal changes in the prevalence of IE. In total 69 021, distributed with 15 350, 16 726, 19 251, and 17 694 BSIs were identified in the periods of 2010-2011, 2012-2013, 2014-2015, and 2016-2017, respectively. Patients with E. faecalis had the highest prevalence of IE (16.7%) followed by S. aureus (10.1%), Streptococcus spp. (7.3%), and CoNS (1.6%). Throughout the study period, the prevalence of IE among patients with E. faecalis and Streptococcus spp. increased significantly (P = 0.0005 and P = 0.03, respectively). Male patients had a higher prevalence of IE for E. faecalis, Streptococcus spp., and CoNS compared with females. A significant increase in the prevalence of IE was seen for E. faecalis, Streptococcus spp., and CoNS with increasing age.

Conclusion: For E. faecalis BSI, 1 in 6 had IE, for S. aureus BSI 1 in 10 had IE, and for Streptococcus spp. 1 in 14 had IE. Our results suggest that screening for IE seems reasonable in patients with E. faecalis BSI, S. aureus BSI, or Streptococcus spp. BSI.

Citing Articles

In Vitro Activity of Ampicillin Plus Ceftriaxone Against Non- and Non- Enterococcal Isolates With/Without VanC Phenotype: Clinical Implications for Infective Endocarditis.

Garcia-Gonzalez J, Canas M, Cuervo G, Hernandez-Meneses M, Verdejo M, Bodro M Microorganisms. 2025; 12(12.

PMID: 39770714 PMC: 11677854. DOI: 10.3390/microorganisms12122511.


Streptococcus suis infective endocarditis in patients with Streptococcus suis bacteremia: a retrospective study of prevalence and outcomes.

Kedsawadevong P, Jamnongprasatporn S, Ratanasit N BMC Infect Dis. 2024; 24(1):1304.

PMID: 39543529 PMC: 11566380. DOI: 10.1186/s12879-024-10180-y.


Outpatient parenteral antimicrobial therapy for patients with endocarditis using continuous infusion IV benzylpenicillin plus IV ceftriaxone.

Briggs S, Duffy E, Bhally H, Broom M, Campbell P, Lane R JAC Antimicrob Resist. 2024; 6(5):dlae168.

PMID: 39464856 PMC: 11503647. DOI: 10.1093/jacamr/dlae168.


Aortic and Mitral Valve Endocarditis-Simply Left-Sided Endocarditis or Different Entities Requiring Individual Consideration?-Insights from the CAMPAIGN Database.

Weber C, Marin-Cuartas M, Tugtekin S, Diab M, Saha S, Akhyari P J Clin Med. 2024; 13(19).

PMID: 39407901 PMC: 11477404. DOI: 10.3390/jcm13195841.


25 years of experience on the management of enterococcal infective endocarditis an observational study.

Schubert L, Chen R, Weiss-Tessbach M, Kriz R, Obermuller M, Jackwerth M Infection. 2024; 53(1):467-474.

PMID: 39404980 PMC: 11825611. DOI: 10.1007/s15010-024-02407-6.